参考文献/References:
[1] Hao L,Zou Z,Tian H,et al.Stem cell-based therapies for ischemic stroke[OL].Biomed Res Int,2014.doi: 10.1155/2014/468748.
[2] Wang J,Huang Q,Ding J,et al.Elevated serum levels of brain-derived neurotrophic factor and miR-124 in acute ischemic strokepatients and the molecular mechanism[J].3 Biotech,2019,9(11):386.
[3] Khatri R,Mckinney AM,Swenson BA.Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke[J].Neurology,2012,79(13, 1):S52-S57.
[4] Zhang H,Meng J,Li X,et al.Pro-GLP-1,a pro-drug of GLP-1,is neuroprotective in cerebral ischemia[J].Eur J Pharm Sci,2015,5(70):82-91.
[5] Teramoto S,Miyamoto N,Yatomi KA,et al.Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia[J].Journal of Cerebral Blood Flow and Metabolism,2011,31(8):1696-1705.
[6] Deacon CF,Pridal L,Klarskov L,et al.Glucagon-like peptide 1 undergos differential tissue-specific metabolism in the anesthetized pig[J].Am J Physiol,1996,271(3):458-464.
[7] Nielsen LL,YoungAA,Parkes DG.Pharmacology of exenatide(synthetic exendin-4):a potential therapeutic for improved glycemic control of type 2 diabetes[J].Regul Pept,2004,117(2):77-88.
[8] Ma X,Meng J,Jia M,et al.Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats[J].J Bone Miner Res,2013,28(7):1641-1652.
[9] Mcbride DW,Zhang JH.Precision stroke animal models:the permanent MCAO model should be the primary model,not transient MCAO[OL].Transl Stroke Res[Z],2017.
[10] Bertilsson G,Patrone C,Zachrisson OA,et al.Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease[J].J Neurosci Res,2008,86(2):326-338.
[11] Harkavyi A,Abuirmeileh A,Lever R,et al.Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease[J].J Neuroinflammation,2008,doi:10.1186/1742-2094-5-19.
[12] Love S.Oxidative stress in brain ischemia[J].Brain Pathol,1999,9(1):119-131.
[13] Han L,Yu Y,Sun X,et al.Exendin-4 directly improves endothelial dysfunction in isolated aortas from obese rats through the cAMP or AMPK-eNOS pathways[J].Diabetes Res Clin Pract,2012,97(3):453-460.
[14] Liebner S,Corada M,Bangsow T,et al.Wnt/beta-catenin signaling controls development of the blood-brain barrier[J].J Cell Biol,2008,183(3):409-417.
[15] Moghaddam HK,Baluchnejadmojarad T,Roghani M,et al.Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats[J].Mol Neurobiol,2014,49(2):820-826.
[16] Briyal S SS,Ischemia Effects of Liraglutide in the Rat Brain Following Focal Cerebral Anti-apoptotic.Neuroscience[Z],2014.
[17] Guyton J,Jeon M,Brooks A.Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus[J].Am J Health Syst Pharm,2019,76(21):1739-1748.
[18] Meller R,Minami M,Cameron JA,et al.CREB-mediated Bcl-2 protein expression after ischemic preconditioning[J].J Cereb Blood Flow Metab,2005,25(2):234-246.
[19] Hockenbery DM,Oltvai ZN,Yin XM,et al.Bcl-2 functions in an antioxidant pathway to prevent apoptosis[J].Cell,1993,75(2):241-251.
[20] Chien CT,Ming JJ,Yc T,et al.Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats[J].J Cereb Blood Flow Metab,2015,35(11):1790-1803.